Cargando…

Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients

SIMPLE SUMMARY: Prostate cancer (PCa) is the most commonly diagnosed non-skin cancer in men and one of the leading causes of cancer-related death. The driver of PCa proliferation and growth is the androgen receptor (AR) and inhibiting this receptor is the standard of care for patients, following sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Lallous, Nada, Snow, Oliver, Sanchez, Christophe, Parra Nuñez, Ana Karla, Sun, Bei, Hussain, Ahmed, Lee, Joseph, Morin, Helene, Leblanc, Eric, Gleave, Martin E., Cherkasov, Artem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230763/
https://www.ncbi.nlm.nih.gov/pubmed/34208290
http://dx.doi.org/10.3390/cancers13122939